Togo

Togo

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
5.03 (4.36 - 5.66) 2019 Modelled IHME
5.45 (4.76 - 6.02) 2018 Modelled IHME
5.68 (4.96 - 6.31) 2017 Modelled IHME
5.74 (4.97 - 6.40) 2016 Modelled IHME
5.79 (4.98 - 6.54) 2015 Modelled IHME
5.9 (5.07 - 6.66) 2014 Modelled IHME
6.07 (5.24 - 6.83) 2013 Modelled IHME
6.27 (5.46 - 7.03) 2012 Modelled IHME
6.48 (5.69 - 7.27) 2011 Modelled IHME
6.67 (5.87 - 7.51) 2010 Modelled IHME
6.87 (6.05 - 7.70) 2009 Modelled IHME
7.09 (6.27 - 7.96) 2008 Modelled IHME
7.3 (6.44 - 8.24) 2007 Modelled IHME
7.46 (6.55 - 8.46) 2006 Modelled IHME
7.54 (6.58 - 8.63) 2005 Modelled IHME
7.56 (6.61 - 8.53) 2004 Modelled IHME
7.57 (6.65 - 8.52) 2003 Modelled IHME
7.57 (6.65 - 8.52) 2002 Modelled IHME
7.58 (6.64 - 8.52) 2001 Modelled IHME
7.6 (6.62 - 8.59) 2000 Modelled IHME
7.65 (6.65 - 8.64) 1999 Modelled IHME
7.74 (6.66 - 8.76) 1998 Modelled IHME
7.84 (6.68 - 8.95) 1997 Modelled IHME
7.92 (6.69 - 9.09) 1996 Modelled IHME
7.96 (6.70 - 9.20) 1995 Modelled IHME
7.96 (6.75 - 9.14) 1994 Modelled IHME
7.95 (6.76 - 9.11) 1993 Modelled IHME
7.94 (6.78 - 9.07) 1992 Modelled IHME
7.92 (6.84 - 9) 1991 Modelled IHME
7.88 (6.85 - 8.88) 1990 Modelled IHME
8.44 (5.28 - 12.43) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.84 (0.65 - 1.05) 2019 Modelled IHME
0.93 (0.73 - 1.16) 2018 Modelled IHME
0.99 (0.77 - 1.27) 2017 Modelled IHME
1.04 (0.81 - 1.30) 2016 Modelled IHME
1.09 (0.83 - 1.38) 2015 Modelled IHME
1.16 (0.88 - 1.44) 2014 Modelled IHME
1.22 (0.94 - 1.52) 2013 Modelled IHME
1.3 (1 - 1.61) 2012 Modelled IHME
1.41 (1.09 - 1.74) 2011 Modelled IHME
1.55 (1.19 - 1.91) 2010 Modelled IHME
2.1 (1.64 - 2.60) 2009 Modelled IHME
3.19 (2.48 - 4) 2008 Modelled IHME
4.43 (3.43 - 5.64) 2007 Modelled IHME
5.46 (4.24 - 6.99) 2006 Modelled IHME
5.89 (4.53 - 7.53) 2005 Modelled IHME
5.9 (4.58 - 7.54) 2004 Modelled IHME
5.89 (4.60 - 7.41) 2003 Modelled IHME
5.89 (4.60 - 7.37) 2002 Modelled IHME
5.88 (4.61 - 7.35) 2001 Modelled IHME
5.89 (4.61 - 7.37) 2000 Modelled IHME
5.94 (4.70 - 7.40) 1999 Modelled IHME
6.06 (4.79 - 7.57) 1998 Modelled IHME
6.21 (4.86 - 7.75) 1997 Modelled IHME
6.32 (4.98 - 7.90) 1996 Modelled IHME
6.37 (4.95 - 7.97) 1995 Modelled IHME
6.37 (4.96 - 7.99) 1994 Modelled IHME
6.34 (4.94 - 7.89) 1993 Modelled IHME
6.3 (4.95 - 7.82) 1992 Modelled IHME
6.23 (4.90 - 7.78) 1991 Modelled IHME
6.12 (4.79 - 7.72) 1990 Modelled IHME
3.36 (1.90 - 5.52) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
288,509 (251,010 - 325,379) 1990 Modelled IHME
299,002 (258,446 - 339,966) 1991 Modelled IHME
309,102 (264,030 - 352,872) 1992 Modelled IHME
318,893 (271,067 - 365,366) 1993 Modelled IHME
328,475 (278,612 - 377,298) 1994 Modelled IHME
337,998 (284,625 - 390,765) 1995 Modelled IHME
346,127 (292,355 - 397,038) 1996 Modelled IHME
352,127 (300,262 - 402,081) 1997 Modelled IHME
357,222 (307,753 - 404,568) 1998 Modelled IHME
362,807 (315,310 - 409,746) 1999 Modelled IHME
370,382 (322,758 - 418,874) 2000 Modelled IHME
379,799 (332,788 - 426,821) 2001 Modelled IHME
389,737 (342,396 - 438,213) 2002 Modelled IHME
400,025 (351,593 - 450,456) 2003 Modelled IHME
410,470 (359,136 - 463,480) 2004 Modelled IHME
420,824 (366,926 - 481,486) 2005 Modelled IHME
428,016 (375,824 - 485,203) 2006 Modelled IHME
430,215 (379,637 - 485,652) 2007 Modelled IHME
429,167 (379,227 - 481,688) 2008 Modelled IHME
426,900 (376,265 - 478,681) 2009 Modelled IHME
425,679 (374,998 - 479,536) 2010 Modelled IHME
424,511 (372,775 - 476,433) 2011 Modelled IHME
421,696 (367,015 - 473,158) 2012 Modelled IHME
418,743 (361,180 - 470,884) 2013 Modelled IHME
417,350 (358,642 - 471,253) 2014 Modelled IHME
419,409 (360,873 - 473,971) 2015 Modelled IHME
425,589 (368,345 - 474,258) 2016 Modelled IHME
430,924 (375,725 - 478,621) 2017 Modelled IHME
422,351 (369,301 - 466,570) 2018 Modelled IHME
398,285 (345,751 - 448,331) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
9 (6.37 - 12.20) 2019 Modelled IHME
9.88 (7.09 - 13.40) 2018 Modelled IHME
10.3 (7.45 - 13.80) 2017 Modelled IHME
10.1 (7.34 - 13.60) 2016 Modelled IHME
9.96 (7.30 - 13.40) 2015 Modelled IHME
10 (7.32 - 13.40) 2014 Modelled IHME
10 (7.40 - 13.30) 2013 Modelled IHME
10.3 (7.63 - 13.60) 2012 Modelled IHME
10.8 (8.13 - 14.10) 2011 Modelled IHME
11.4 (8.54 - 14.90) 2010 Modelled IHME
11.5 (8.68 - 15) 2009 Modelled IHME
11.7 (8.84 - 15.10) 2008 Modelled IHME
12 (9.03 - 15.40) 2007 Modelled IHME
12.3 (9.19 - 16) 2006 Modelled IHME
12.6 (9.35 - 16.60) 2005 Modelled IHME
12.6 (9.22 - 16.40) 2004 Modelled IHME
12.7 (9.38 - 16.60) 2003 Modelled IHME
12.5 (9.26 - 16.20) 2002 Modelled IHME
12.3 (9.31 - 15.80) 2001 Modelled IHME
12.1 (9.28 - 15.40) 2000 Modelled IHME
12 (9.26 - 15.20) 1999 Modelled IHME
12.1 (9.44 - 15.30) 1998 Modelled IHME
12.1 (9.33 - 15.30) 1997 Modelled IHME
12.1 (9.25 - 15.20) 1996 Modelled IHME
12 (9.20 - 15.10) 1995 Modelled IHME
12 (9.11 - 15.20) 1994 Modelled IHME
11.9 (9.03 - 15.30) 1993 Modelled IHME
12 (8.85 - 15.30) 1992 Modelled IHME
12 (8.83 - 15.40) 1991 Modelled IHME
12 (8.88 - 15.50) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
713 (505 - 966) 2019 Modelled IHME
766 (550 - 1,038) 2018 Modelled IHME
782 (565 - 1,047) 2017 Modelled IHME
749 (544 - 1,011) 2016 Modelled IHME
721 (528 - 974) 2015 Modelled IHME
707 (517 - 946) 2014 Modelled IHME
693 (511 - 920) 2013 Modelled IHME
695 (513 - 915) 2012 Modelled IHME
705 (533 - 922) 2011 Modelled IHME
726 (545 - 951) 2010 Modelled IHME
716 (540 - 935) 2009 Modelled IHME
708 (535 - 912) 2008 Modelled IHME
704 (532 - 905) 2007 Modelled IHME
706 (527 - 919) 2006 Modelled IHME
705 (522 - 925) 2005 Modelled IHME
686 (501 - 892) 2004 Modelled IHME
669 (496 - 877) 2003 Modelled IHME
641 (477 - 833) 2002 Modelled IHME
615 (466 - 791) 2001 Modelled IHME
590 (452 - 752) 2000 Modelled IHME
571 (440 - 720) 1999 Modelled IHME
561 (436 - 705) 1998 Modelled IHME
545 (419 - 688) 1997 Modelled IHME
527 (404 - 665) 1996 Modelled IHME
510 (391 - 644) 1995 Modelled IHME
494 (376 - 626) 1994 Modelled IHME
479 (362 - 612) 1993 Modelled IHME
466 (344 - 596) 1992 Modelled IHME
454 (334 - 583) 1991 Modelled IHME
441 (325 - 568) 1990 Modelled IHME
1,139 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
50 (42 - 59) 2019 Modelled IHME
52 (44 - 61) 2018 Modelled IHME
52 (44 - 61) 2017 Modelled IHME
52 (44 - 61) 2016 Modelled IHME
52 (44 - 61) 2015 Modelled IHME
52 (44 - 61) 2014 Modelled IHME
53 (44 - 61) 2013 Modelled IHME
53 (44 - 61) 2012 Modelled IHME
53 (45 - 61) 2011 Modelled IHME
53 (45 - 61) 2010 Modelled IHME
53 (45 - 61) 2009 Modelled IHME
53 (45 - 61) 2008 Modelled IHME
54 (46 - 62) 2007 Modelled IHME
54 (46 - 62) 2006 Modelled IHME
54 (46 - 62) 2005 Modelled IHME
54 (46 - 62) 2004 Modelled IHME
54 (46 - 62) 2003 Modelled IHME
54 (46 - 62) 2002 Modelled IHME
54 (46 - 63) 2001 Modelled IHME
54 (46 - 63) 2000 Modelled IHME
54 (46 - 63) 1999 Modelled IHME
54 (46 - 63) 1998 Modelled IHME
54 (46 - 63) 1997 Modelled IHME
54 (46 - 62) 1996 Modelled IHME
54 (45 - 62) 1995 Modelled IHME
53 (45 - 62) 1994 Modelled IHME
53 (45 - 62) 1993 Modelled IHME
53 (44 - 61) 1992 Modelled IHME
52 (44 - 61) 1991 Modelled IHME
52 (44 - 61) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
88 2018 Survey/reported WHO/UNICEF
90 2017 Survey/reported WHO/UNICEF
89 2016 Survey/reported WHO/UNICEF
88 2015 Survey/reported WHO/UNICEF
87 2014 Survey/reported WHO/UNICEF
84 2013 Survey/reported WHO/UNICEF
84 2012 Survey/reported WHO/UNICEF
85 2011 Survey/reported WHO/UNICEF
83 2010 Survey/reported WHO/UNICEF
78 2009 Survey/reported WHO/UNICEF
24 2008 Survey/reported WHO/UNICEF
84 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
2.46 (1.97 - 3.11) 2019 Modelled IHME
2.45 (1.96 - 3.08) 2018 Modelled IHME
2.45 (1.96 - 3.08) 2017 Modelled IHME
2.45 (1.98 - 3.09) 2016 Modelled IHME
2.45 (1.98 - 3.08) 2015 Modelled IHME
2.46 (1.98 - 3.08) 2014 Modelled IHME
2.47 (1.99 - 3.10) 2013 Modelled IHME
2.49 (2.01 - 3.12) 2012 Modelled IHME
2.51 (2.02 - 3.14) 2011 Modelled IHME
2.53 (2.02 - 3.17) 2010 Modelled IHME
2.55 (2.03 - 3.20) 2009 Modelled IHME
2.56 (2.03 - 3.22) 2008 Modelled IHME
2.58 (2.04 - 3.24) 2007 Modelled IHME
2.59 (2.04 - 3.26) 2006 Modelled IHME
2.6 (2.06 - 3.29) 2005 Modelled IHME
2.61 (2.06 - 3.29) 2004 Modelled IHME
2.61 (2.07 - 3.29) 2003 Modelled IHME
2.62 (2.08 - 3.31) 2002 Modelled IHME
2.62 (2.08 - 3.31) 2001 Modelled IHME
2.62 (2.08 - 3.32) 2000 Modelled IHME
2.63 (2.10 - 3.32) 1999 Modelled IHME
2.63 (2.12 - 3.33) 1998 Modelled IHME
2.64 (2.13 - 3.32) 1997 Modelled IHME
2.64 (2.13 - 3.33) 1996 Modelled IHME
2.65 (2.14 - 3.33) 1995 Modelled IHME
2.66 (2.15 - 3.33) 1994 Modelled IHME
2.67 (2.15 - 3.34) 1993 Modelled IHME
2.68 (2.16 - 3.37) 1992 Modelled IHME
2.69 (2.16 - 3.37) 1991 Modelled IHME
2.7 (2.15 - 3.39) 1990 Modelled IHME
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
98,954 (78,598 - 124,257) 1990 Modelled IHME
101,544 (81,505 - 127,345) 1991 Modelled IHME
104,192 (83,972 - 131,005) 1992 Modelled IHME
106,905 (86,256 - 134,089) 1993 Modelled IHME
109,690 (88,561 - 137,586) 1994 Modelled IHME
112,568 (90,768 - 141,657) 1995 Modelled IHME
115,523 (93,195 - 145,423) 1996 Modelled IHME
118,521 (95,479 - 149,113) 1997 Modelled IHME
121,574 (97,868 - 153,612) 1998 Modelled IHME
124,705 (99,572 - 157,743) 1999 Modelled IHME
127,920 (101,243 - 161,689) 2000 Modelled IHME
131,235 (104,321 - 165,858) 2001 Modelled IHME
134,654 (107,232 - 170,301) 2002 Modelled IHME
138,157 (109,539 - 174,176) 2003 Modelled IHME
141,724 (112,007 - 178,551) 2004 Modelled IHME
145,319 (114,792 - 183,604) 2005 Modelled IHME
148,791 (117,030 - 187,211) 2006 Modelled IHME
152,059 (120,470 - 191,177) 2007 Modelled IHME
155,202 (122,725 - 195,004) 2008 Modelled IHME
158,326 (126,000 - 198,713) 2009 Modelled IHME
161,554 (128,669 - 202,590) 2010 Modelled IHME
164,722 (132,153 - 205,938) 2011 Modelled IHME
167,701 (134,996 - 209,999) 2012 Modelled IHME
170,680 (137,297 - 213,548) 2013 Modelled IHME
173,882 (140,134 - 217,822) 2014 Modelled IHME
177,562 (143,346 - 223,390) 2015 Modelled IHME
181,695 (146,705 - 228,877) 2016 Modelled IHME
185,924 (148,823 - 233,224) 2017 Modelled IHME
190,242 (152,242 - 238,494) 2018 Modelled IHME
194,785 (155,801 - 246,412) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
1.46 (1 - 2.11) 2019 Modelled IHME
1.36 (0.93 - 1.95) 2018 Modelled IHME
1.33 (0.91 - 1.88) 2017 Modelled IHME
1.29 (0.88 - 1.81) 2016 Modelled IHME
1.27 (0.87 - 1.78) 2015 Modelled IHME
1.28 (0.88 - 1.81) 2014 Modelled IHME
1.29 (0.89 - 1.84) 2013 Modelled IHME
1.34 (0.94 - 1.89) 2012 Modelled IHME
1.4 (0.99 - 1.96) 2011 Modelled IHME
1.47 (1.03 - 2.06) 2010 Modelled IHME
1.46 (1.02 - 2.04) 2009 Modelled IHME
1.45 (1.02 - 2.01) 2008 Modelled IHME
1.44 (1.02 - 2) 2007 Modelled IHME
1.45 (1.02 - 2) 2006 Modelled IHME
1.46 (1.04 - 2.03) 2005 Modelled IHME
1.47 (1.03 - 2.02) 2004 Modelled IHME
1.48 (1.05 - 2.02) 2003 Modelled IHME
1.48 (1.04 - 2.02) 2002 Modelled IHME
1.47 (1.05 - 1.98) 2001 Modelled IHME
1.47 (1.06 - 2) 2000 Modelled IHME
1.48 (1.07 - 1.99) 1999 Modelled IHME
1.49 (1.09 - 1.98) 1998 Modelled IHME
1.49 (1.09 - 1.98) 1997 Modelled IHME
1.48 (1.10 - 1.98) 1996 Modelled IHME
1.48 (1.09 - 1.94) 1995 Modelled IHME
1.48 (1.09 - 1.95) 1994 Modelled IHME
1.48 (1.08 - 1.94) 1993 Modelled IHME
1.49 (1.08 - 1.96) 1992 Modelled IHME
1.5 (1.10 - 2) 1991 Modelled IHME
1.52 (1.09 - 2.03) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
115 (79 - 167) 2019 Modelled IHME
105 (72 - 151) 2018 Modelled IHME
101 (69 - 142) 2017 Modelled IHME
96 (66 - 135) 2016 Modelled IHME
92 (63 - 129) 2015 Modelled IHME
90 (62 - 128) 2014 Modelled IHME
89 (62 - 127) 2013 Modelled IHME
90 (63 - 127) 2012 Modelled IHME
92 (65 - 129) 2011 Modelled IHME
94 (66 - 132) 2010 Modelled IHME
91 (63 - 127) 2009 Modelled IHME
88 (62 - 121) 2008 Modelled IHME
85 (60 - 118) 2007 Modelled IHME
83 (59 - 115) 2006 Modelled IHME
82 (58 - 113) 2005 Modelled IHME
80 (56 - 110) 2004 Modelled IHME
78 (55 - 107) 2003 Modelled IHME
76 (54 - 104) 2002 Modelled IHME
74 (53 - 99) 2001 Modelled IHME
72 (51 - 97) 2000 Modelled IHME
70 (51 - 94) 1999 Modelled IHME
69 (50 - 92) 1998 Modelled IHME
67 (49 - 89) 1997 Modelled IHME
65 (48 - 87) 1996 Modelled IHME
63 (46 - 83) 1995 Modelled IHME
61 (45 - 81) 1994 Modelled IHME
59 (43 - 78) 1993 Modelled IHME
58 (42 - 76) 1992 Modelled IHME
57 (41 - 76) 1991 Modelled IHME
56 (40 - 74) 1990 Modelled IHME
274 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
17 (12 - 23) 2019 Modelled IHME
17 (11 - 22) 2018 Modelled IHME
17 (11 - 23) 2017 Modelled IHME
17 (11 - 22) 2016 Modelled IHME
17 (11 - 23) 2015 Modelled IHME
17 (11 - 22) 2014 Modelled IHME
17 (11 - 22) 2013 Modelled IHME
17 (11 - 22) 2012 Modelled IHME
16 (11 - 22) 2011 Modelled IHME
16 (11 - 22) 2010 Modelled IHME
16 (11 - 22) 2009 Modelled IHME
16 (11 - 22) 2008 Modelled IHME
16 (11 - 22) 2007 Modelled IHME
16 (11 - 22) 2006 Modelled IHME
16 (11 - 22) 2005 Modelled IHME
16 (11 - 22) 2004 Modelled IHME
16 (11 - 21) 2003 Modelled IHME
16 (11 - 21) 2002 Modelled IHME
16 (11 - 22) 2001 Modelled IHME
15 (11 - 22) 2000 Modelled IHME
15 (10 - 21) 1999 Modelled IHME
15 (10 - 21) 1998 Modelled IHME
15 (10 - 21) 1997 Modelled IHME
16 (10 - 21) 1996 Modelled IHME
16 (11 - 22) 1995 Modelled IHME
16 (11 - 22) 1994 Modelled IHME
16 (11 - 22) 1993 Modelled IHME
16 (11 - 22) 1992 Modelled IHME
17 (12 - 23) 1991 Modelled IHME
17 (12 - 23) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
Few (1-10%)

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
713
2019
(505 - 966)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
115
2019
(79 - 167)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines